Vascular brachytherapy vs. drug-eluting stents for the treatment of in-stent restenosis: The jury's still out

Catheterization and Cardiovascular Interventions

Volumn 62, Issue 3, 2004, Pages 290-291

  Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; BRACHYTHERAPY; CORONARY STENT; DRUG ELUTING STENT; EDITORIAL; HUMAN; RESTENOSIS; THROMBOSIS;

BRACHYTHERAPY; CORONARY RESTENOSIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 3042743474     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20154     Document Type: Editorial

References (13)

1. Waksman R, White LR, Chan RC, et al. Intracoronary 1-radiation therapy after angioplasty inhibits recurrence in patients with instent restenosis. Circulation 2000;101:2165-2171.
2. Leon MB, Teirstein PS, Moses JW, et al. Localized intracoronary 1-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001;334:250-256.
3. Waksman R, Ajani AE, White RL, et al. Intravascular 1 radiation for in-stent restenosis in saphenous vein bypass grafts. N Engl J Med 2002;346:1194-1199.
4. 90Y β-radiation versus placebo control for treatment of in-stent restenosis. Circulation 2002;106:1090-1096.
5. Waksman R, Raizner AE, Yeung AC, et al. Use of localized intracoronary β radiation in treatment of in-stent restenosis: the INHIBIT randomized controlled trial. Lancet 2002;359:543-544.
6. Gruberg L, Waksman R, Ajani AE, et al. The effect of intracoronary radiation for the treatment of recurrent in-stent restenosis in patients with diabetes mellitus. J Am Coll Cardiol 2002;39:1930-1936.
7. Albiero R, Silber S, Di Mario C, et al. Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT). J Am Coll Cardiol 2004;43:936-942.
8. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
9. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
10. Sousa JE, Costa MA, Abizaid A, et al. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2003;107:24-27.
11. Degertekin M, Regar E, Tanabe K, et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience. J Am Coll Cardiol 2003;41:184-189.
12. Saia F, Lemos PA, Hoye A, et al. Clinical outcomes for Sirolimus-eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis. Catheter Cardiovasc Interv 2004; 62:283-288.
13. Waksman R, Buchbinder M, Reisman M, et al. Balloon-based radiation therapy for treatment of in-stent restenosis in human coronary arteries: results from the BRITE I study. Catheter Cardiovasc Interv 2002;57:286-294.